Agnes A. Mooslechner

413 total citations
13 papers, 125 citations indexed

About

Agnes A. Mooslechner is a scholar working on Nephrology, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Agnes A. Mooslechner has authored 13 papers receiving a total of 125 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Nephrology, 2 papers in Pharmacology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Agnes A. Mooslechner's work include Renal Diseases and Glomerulopathies (3 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (2 papers) and Renal Transplantation Outcomes and Treatments (2 papers). Agnes A. Mooslechner is often cited by papers focused on Renal Diseases and Glomerulopathies (3 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (2 papers) and Renal Transplantation Outcomes and Treatments (2 papers). Agnes A. Mooslechner collaborates with scholars based in Austria, Germany and United Kingdom. Agnes A. Mooslechner's co-authors include Alexander R. Rosenkranz, Alexander H. Kirsch, Philipp Eller, Kathrin Eller, Christian Meisel, Ákos Heinemann, Patricia Grabowski, Hans‐Dieter Volk, Leif G. Hanitsch and Marion J. Pollheimer and has published in prestigious journals such as Kidney International, American Journal Of Pathology and European Journal of Immunology.

In The Last Decade

Agnes A. Mooslechner

13 papers receiving 122 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Agnes A. Mooslechner	36	33	24	21	19	13	125
Rebecca Danning	32 0.9×	8 0.2×	13 0.5×	14 0.7×	8 0.4×	3	155
Marianna Pezzella	48 1.3×	11 0.3×	12 0.5×	57 2.7×	8 0.4×	15	217
Tiziana Tassinari	35 1.0×	18 0.5×	10 0.4×	5 0.2×	6 0.3×	10	101
Ying Ding	10 0.3×	13 0.4×	13 0.5×	34 1.6×	11 0.6×	27	207
Flavio Bellante	46 1.3×	6 0.2×	9 0.4×	14 0.7×	5 0.3×	7	109
Jing Shen	21 0.6×	31 0.9×	37 1.5×	24 1.1×	7 0.4×	20	167
Suzanne Schol‐Gelok	17 0.5×	6 0.2×	37 1.5×	15 0.7×	11 0.6×	8	117
Riccardo Giossi	30 0.8×	19 0.6×	9 0.4×	23 1.1×	3 0.2×	15	144
Sedat Şen	15 0.4×	6 0.2×	13 0.5×	15 0.7×	24 1.3×	18	150
Lars Kjærsgaard Hansen	19 0.5×	49 1.5×	28 1.2×	44 2.1×	2 0.1×	16	181

Countries citing papers authored by Agnes A. Mooslechner

Since Specialization

Citations

This map shows the geographic impact of Agnes A. Mooslechner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnes A. Mooslechner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnes A. Mooslechner more than expected).

Fields of papers citing papers by Agnes A. Mooslechner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agnes A. Mooslechner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnes A. Mooslechner. The network helps show where Agnes A. Mooslechner may publish in the future.

Co-authorship network of co-authors of Agnes A. Mooslechner

This figure shows the co-authorship network connecting the top 25 collaborators of Agnes A. Mooslechner. A scholar is included among the top collaborators of Agnes A. Mooslechner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agnes A. Mooslechner. Agnes A. Mooslechner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Mooslechner, Agnes A., Barbara Prietl, Alexander H. Kirsch, et al.. (2025). T cell Activation Marker HLA-DR Reflects Tacrolimus-Associated Immunosuppressive Burden and BK Viremia Risk After Kidney Transplantation – An Observational Cohort Study. Transplant International. 38. 14443–14443. 1 indexed citations

Mooslechner, Agnes A., Wolfgang Platzer, Clemens Aigner, et al.. (2025). Succinate aggravates pulmonary fibrosis through the succinate/SUCNR1 axis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 328(5). L671–L684. 2 indexed citations

Mooslechner, Agnes A., et al.. (2025). Deficiency of the Synaptic Adhesion Protein Leucine‐Rich Repeat Transmembrane Protein 4 Like 1 Affects Anxiety and Aggression in Zebrafish. Acta Physiologica. 241(5). e70042–e70042. 1 indexed citations

Mooslechner, Agnes A., Barbara Prietl, Alexander H. Kirsch, et al.. (2024). Pre-Transplant Frequencies of FoxP3+CD25+ in CD3+CD8+ T Cells as Potential Predictors for CMV in CMV-Intermediate Risk Kidney Transplant Recipients. Transplant International. 37. 12963–12963. 2 indexed citations

Hahn, Anne M., Annika Hausmann, Gizem Kılıç, et al.. (2023). Young EFIS: Three years of progress – Reflecting on achievements and embracing new horizons. European Journal of Immunology. 53(12). e2350749–e2350749. 1 indexed citations

Kirsch, Alexander H., Agnes A. Mooslechner, Alexander R. Rosenkranz, et al.. (2022). B Cell Composition Is Altered After Kidney Transplantation and Transitional B Cells Correlate With SARS-CoV-2 Vaccination Response. Frontiers in Medicine. 9. 818882–818882. 8 indexed citations

Mooslechner, Agnes A., Katharina Artinger, Alexander H. Kirsch, et al.. (2022). Low-Dose rIL-15 Protects from Nephrotoxic Serum Nephritis via CD8+ T Cells. Cells. 11(22). 3656–3656. 2 indexed citations

Artinger, Katharina, Alexander H. Kirsch, Agnes A. Mooslechner, et al.. (2021). Blockade of tumor necrosis factor superfamily members CD30 and OX40 abrogates disease activity in murine immune-mediated glomerulonephritis. Kidney International. 100(2). 336–348. 5 indexed citations

Artinger, Katharina, Thomas Bärnthaler, Agnes A. Mooslechner, et al.. (2021). Agonism of Prostaglandin E2 Receptor 4 Ameliorates Tubulointerstitial Injury in Nephrotoxic Serum Nephritis in Mice. Journal of Clinical Medicine. 10(4). 832–832. 3 indexed citations

10.

Kirsch, Alexander H., Katharina Artinger, Agnes A. Mooslechner, et al.. (2019). Glucagon-Like Peptide-1 Receptor Agonism Improves Nephrotoxic Serum Nephritis by Inhibiting T-Cell Proliferation. American Journal Of Pathology. 190(2). 400–411. 49 indexed citations

11.

Artinger, Katharina, Alexander H. Kirsch, Katharina Jandl, et al.. (2018). Blockade of prostaglandin E₂ receptor 4 ameliorates nephrotoxic serum nephritis. American Journal of Physiology-Renal Physiology. 315(6). F1869–F1880. 11 indexed citations

12.

Loebel, Madlen, Agnes A. Mooslechner, Michael Knops, et al.. (2015). Frequent IgG subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome. Human Immunology. 76(10). 729–735. 25 indexed citations

13.

Löbel, Madlen, Agnes A. Mooslechner, Sandra Bauer, et al.. (2015). Polymorphism in COMT is associated with IgG3 subclass level and susceptibility to infection in patients with chronic fatigue syndrome. Journal of Translational Medicine. 13(1). 264–264. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact